The purpose of this study is to evaluate the effects of intranasal oxytocin on bone density, structure and strength in children with autism spectrum disorder (ASD).

Childhood and adolescence are a critical time for the growth and strengthening the skeletal system. Children with ASD have lower bone density which puts them at higher risk for bone fracture and long-term issues with bone health.

We hope to learn more about the impact of the investigational drug for the treatment of bone health in children with ASD.